Ad Claims, Q3 Results, Private Placement: Health & Wellness Industry News
This article was originally published in The Rose Sheet
NAD tips Balance of Nature claim to FTC; Vitamin Shoppe sales down 8.5%; ChromaDex gains $23m in private placement; and more health and wellness news in brief.
You may also be interested in...
A February 2019 inspection of Balance of Nature’s manufacturing facility in St. George, UT, led FDA to claims on the firm's branded website and YouTube channel, which the agency says mark its products as unapproved drugs. Meanwhile, the site inspection turned up quality control and procedural documentation issues that still need to be resolved.
The firm has looked to boost sales through a retail re-invention strategy for improving customers' shopping experience with better store layouts, product assortment and website improvements. Now it’s using tools “directly focused on customer acquisition, price/value and customer retention,” CEO Colin Watts says.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.